Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1012 | 998 | 1115 | 1002 | 1095 | 1387 |
Fund Return | 1.16% | -0.24% | 11.54% | 0.05% | 1.82% | 3.33% |
Place in category | 575 | 877 | 90 | 499 | 271 | 48 |
% in Category | 56 | 90 | 11 | 62 | 40 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea Korko A K EUR | 3.42B | 1.44 | 1.58 | 0.39 | ||
Nordea Korko A T EUR | 3.42B | 1.44 | 1.58 | 0.39 | ||
Nordea Korko S K EUR | 3.42B | 1.49 | 1.64 | 0.47 | ||
Nordea Korko I T EUR | 3.42B | 1.47 | 1.64 | 0.45 | ||
Nordea Korko I K EUR | 3.42B | 1.47 | 1.64 | 0.45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
OP High Yield A | 478.69M | 1.12 | 1.04 | 2.65 | ||
OP High Yield B | 478.69M | 1.12 | 1.04 | 2.65 | ||
Alandsbanken Euro High Yield B | 236.62M | 2.22 | 0.77 | 2.26 | ||
FIM European HY ESG | 197.23M | 1.34 | 4.07 | 3.23 | ||
Taaleri Higher Yields A | 144.09M | 3.94 | 0.69 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Euro Schatz Future June 24 | DE000C75XMW4 | 16.61 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | XS2406607171 | 2.41 | - | - | |
Electricite de France SA 3.375% | FR0013534336 | 2.11 | - | - | |
VMED O2 UK Financing I PLC 4% | XS2231189924 | 2.08 | - | - | |
Virgin Media Vendor Financing Notes III Designated Activity Company 4.875% | XS2187646901 | 1.99 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review